-
"Clinicians at my family planning facility often refuse to give a birth control method if the patient is late for her annual exam," says a respondent to the 2010 Contraceptive Technology Update Contraception Survey.
-
Among the seemingly countless provisions in the March 2010 health reform law is one that greatly simplifies the process by which a state may extend Medicaid eligibility for family planning services and supplies to individuals ineligible for comprehensive health coverage under the program.
-
Can same pre-exposure prophylaxis results be recreated in real life?
-
Add new information in your counseling dialogue regarding the human papillomavirus (HPV) vaccine Gardasil.
-
-
The results of this well-done study suggest that a specific formulation of echinacea may offer modest benefit to people with the common cold, but that such benefit is statistically, and likely clinically, insignificant. Data from the trial relating to physician-patient interaction and clinical response have yet to be published.
-
Findings of this ground-breaking randomized controlled trial suggest that patients with irritable bowel syndrome who receive treatment with placebo tablets, and who are fully aware that they are taking a placebo, have significantly greater relief of symptoms compared with patients who receive no treatment at all. Accessing the placebo effect may not require deception at all.
-
Glucosamine sulfate continues to grow in popularity as a treatment for osteoarthritis. Global sales reached almost $2 billion in 2008, an increase of 60 percent over the previous five years.
-
An evaluation of medical research by the IOM establishes new RDAs for vitamin D (600-800 IU) and calcium (700-1300 milligrams).
-
Marine n-3 PUFAs act as pleiotropic agents on the cardiovascular system with a diverse range of effects most of which are beneficial for patients with known cardiovascular disease and possibly, they may even have beneficial effects with regard to the primary prevention of cardiovascular disease.
